Heart rate as a therapeutic target in heart failure?

被引：10
|
作者：
Tavazzi, L [1 ]
机构：
[1] Inst Care Res, Dept Cardiol, Policlin San Matteo, Pavia, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2003年 / 5卷 / 0G期
关键词：
heart rate; heart failure; I-f channel; I-f channel antagonist; ivabradine;
D O I：
10.1016/S1520-765X(03)90003-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A common finding in all clinical trials on heart failure is a negative correlation between heart rate and duration of life. In several studies this was found in both patients taking and those not taking beta-blocker agents. In postinfarct patients increasing mortality with increasing heart rate was found in the absence and in the presence of left ventricular dysfunction. Moreover beneficial effects of neurohormonal modulators were found to be greater in heart failure patients with higher heart rate. Thus heart rate can be considered a target for medical intervention, and therapeutic attempts focused on direct control of heart rate have a good rationale. (C) 2003 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：G15 / G18
页数：4
相关论文
共 50 条
  • [21] Novel drugs for heart rate control in heart failure
    Agata Bielecka-Dabrowa
    Stephan von Haehling
    Jacek Rysz
    Maciej Banach
    Heart Failure Reviews, 2018, 23 : 517 - 525
  • [22] Heart failure: an underestimated therapeutic target in diabetes
    Marx, Nikolaus
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2018, 7 (01) : 10 - 12
  • [23] The interstitial compartment as a therapeutic target in heart failure
    Aronson, Doron
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [24] Is Heart Rate a Norepiphenomenon in Heart Failure?
    Mark Hensey
    James O’Neill
    Current Cardiology Reports, 2016, 18
  • [25] Heart rate in heart failure with preserved ejection fraction: target or marker?
    Kalogeropoulos, Andreas P.
    Butler, Javed
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (11) : 1504 - 1506
  • [26] Heart rate and its reduction in chronic heart failure and beyond
    Vukadinovic, Aleksandra Nikolovska
    Vukadinovic, Davor
    Borer, Jeffrey
    Cowie, Martin
    Komajda, Michel
    Lainscak, Mitja
    Swedberg, Karl
    Boehm, Michael
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (10) : 1230 - 1241
  • [27] Optimized Treatment and Heart Rate Reduction in Chronic Heart Failure
    Moreno, Irineu Blanco
    Del Carlo, Carlos Henrique
    Carlos Pereira-Barretto, Antonio
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 101 (05) : 442 - 447
  • [28] How to consider target heart rate in patients with systolic heart failure
    Izumida, Toshihide
    Imamura, Teruhiko
    Nakamura, Makiko
    Fukuda, Nobuyuki
    Kinugawa, Koihciro
    ESC HEART FAILURE, 2020, 7 (05): : 3231 - 3234
  • [29] Heart rate reduction in heart failure: ivabradine or beta blockers?
    Guglin, Maya
    HEART FAILURE REVIEWS, 2013, 18 (04) : 517 - 528
  • [30] Heart Rate Reduction and the Prognosis of Heart Failure Focused on Ivabradine
    Kiuchi, Shunsuke
    Ikeda, Takanori
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
12345